About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 63634 record(s)
Req # A-2021-001886
Adverse Drug Reactions (ADRs). Report numbers: 000954531, E2B_04316488, E2B_04327327, E2B_03100544, E2B_04466964, E2B_04485974, 000969747.Organization: Health Canada
May 2022
Req # A-2021-001943
Adverse Drug Reactions (ADRs). Report numbers: 000968928, E2B_03958525, E2B_03553644.Organization: Health Canada
May 2022
Req # A-2021-001951
Adverse Drug Reactions (ADRs). Report numbers: 000934489, E2B_02559582, E2B_03541719, 000930400, E2B_03408952.Organization: Health Canada
May 2022
Req # A-2021-001963
Adverse Drug Reactions (ADRs). Report numbers: 000970814, E2B_04790824, E2B_04737471, E2B_04737542.Organization: Health Canada
May 2022
Req # A-2021-001980
Adverse Drug Reactions (ADRs). Report numbers: E2B_04765128, E2B_04807541, E2B_04824570, E2B_04821006, 000973481, E2B_04756344, 000972259, 000970522, 000973760, 000973872, 000972425, E2B_01038775, E2B_01668238, E2B_04750565, E2B_04753860, E2B_04785866, E2B_04831127, 000726401.Organization: Health Canada
May 2022
Req # A-2021-001989
Adverse Drug Reactions (ADRs) for Hydromorphone. Report numbers: E2B_04820013, 000971865. ADR for Balversa. Report number: E2B_03466185. ADRs for Midazolam. Report numbers: E2B_04781876, E2B_04781873.Organization: Health Canada
May 2022
Req # A-2021-002015
Adverse Drug Reaction (ADR) for PMS-SERTRALINE/PMS-QUETIAPINE. Report number: 000968992. ADRs for CLIOQUINOL/FLUMETHASONE PIVALATE. Report numbers: E2B_03328390, E2B_00900035, E2B_00483641.Organization: Health Canada
May 2022
Req # A-2021-002039
Adverse Drug Reactions (ADRs). Report numbers: E2B_04904096, E2B_04938389, E2B_04938394, E2B_04894243, 975179.Organization: Health Canada
May 2022
Req # A-2021-002041
Adverse Drug Reactions (ADRs). Report numbers: 000965936, 000968726.Organization: Health Canada
May 2022
Req # A-2021-002045
Adverse Drug Reactions (ADRs). Report numbers: 951705, 948797, 948430, 951918, 948429, 950383, 952132, 948806, 948427, 948564, 951548, 948733, 949681, 948968, E2B_04215767, 953394, 948395, 949763, 955947, E2B_04279981.Organization: Health Canada
May 2022